Lukman O Afolabi

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum Stress

Breast Cancer Cells

Signaling Pathway

Artificial Intelligence

Top Venues

International journal of molecular sciences

Clinical & translational immunology

Cancer control : journal of the Moffitt Cancer Center

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Li, Jianchao Zhang, Yan Zhu, Lukman O Afolabi, Liang Chen, Xue-Song Feng
Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway. International journal of molecular sciences 24 (9) (2023)
Lukman O Afolabi, Jiacheng Bi, Liang Chen, Xiaolu Yang, Xiaochun Wan
Suppression of protein quality control system by TRIM30a sensitises tumour cells to NK cell-mediated immune surveillance. Immunology (2023)
Jing Li, Jianchao Zhang, Yan Zhu, Lukman O Afolabi, Liang Chen, Xue-Song Feng
Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway. International journal of molecular sciences 24 (9) (2023)
Yan Zhu, Lukman O Afolabi, Xiaochun Wan, Joong Sup Shim, Liang Chen
TRIM family proteins: roles in proteostasis and neurodegenerative diseases. Open biology 12 (8) (2022)
Ibrahim H Musa, Lukman O Afolabi, Ibrahim Zamit, Taha Hussien Musa, Hassan Hussein Musa, Andrew N Tassang, Tosin Yinka Akintunde, Wei Li
Artificial Intelligence and Machine Learning in Cancer Research: A Systematic and Thematic Analysis of the Top 100 Cited Articles Indexed in Scopus Database. Cancer control : journal of the Moffitt Cancer Center 29 (2022)
Lukman O Afolabi, Mariam O Afolabi, Musbahu M Sani, Wahab O Okunowo, Dehong Yan, Liang Chen, Yaou Zhang, Xiaochun Wan
Exploiting the CRISPR-Cas9 gene-editing system for human cancers and immunotherapy. Clinical & translational immunology 10 (6) (2021)